Ascending to improve treatment options, outcomes, and lives

Clinical Trials

Ascendis Pharma is committed to developing a proprietary pipeline of unique products that address unmet patient needs in rare endocrine diseases. Our ongoing clinical trials for TransCon hGH and TransCon PTH are a reflection of that commitment.

TransCon hGH

A phase 3 clinical trial comparing once-weekly TransCon hGH to daily hGH in eligible treatment-naïve, pre-pubertal children with GHD.

For more information visit

heiGHt Trial - logo enliGHten - TransCon hGH: Long-term extension
A phase 3 clinical trial of once-weekly TransCon hGH in GH treatment-experienced children with GHD. fliGHt Trial - logo